Our partners

In the North West, there are multidisciplinary team of doctors, genetic counsellors and clinical scientists provide support to individuals, both adults and children, affected by or at risk of genetic disorders, based at Liverpool Women's Hospital and Manchester University Foundation NHS Trust.

Services include diagnosis:

• Diagnosis of genetic disorders
• Risk assessment and genetic counselling for patients with a family history of an inherited disorder or a family cancer syndrome
• Predictive genetic testing including prenatal diagnosis for some genetic disorders

Liverpool Centre for Genomic Medicine (LCGM)

Liverpool Women’s provides a regional genetics service known as the Merseyside and Cheshire Genetics Service - serving the population across Merseyside, Cheshire and the Isle of Man.

The Genetic Laboratory Service based at the Liverpool Women's Hospital site is now part of Manchester University NHS Foundation Trust, and the North West Genomic Laboratory Hub (NW GLH).

For further information please click here. 

Manchester Centre for Genomic Medicine (MCGM)

Based within Manchester University NHS Foundation Trust , MCGM provides a regional genetics services, working with NW GLH and clinical colleagues from a variety of medical specialties, across Greater Manchester and the North West region. 

For further information please click here.

For information regarding Clinical Genetics Referrals, please refer to the relevant pages below.

For Liverpool Clinical Genetics Referrals, please click here.

For Manchester Clinical Genetics Referrals, please click here.

The NHS North West Genomic Medicine Service Alliance is one of seven established  to support the embedding of genomics into routine healthcare across England.

The other NHS GMS Alliances are:

• NHS North East and Yorkshire GMS Alliance
• NHS East GMS Alliance
• NHS Central and South GMS Alliance
• NHS North Thames GMS Alliance
• NHS South East GMS Alliance
• NHS South West GMS Alliance

Patients and enhanced patient care is at the heart of everything we do, with Patient and Public Voice panel members attending regional partnership and leadership boards, playing a central role in decision making both regionally and nationally, through co-ordination with NHS England.

Formerly known as Health Education England, NHS England's national Genomics Education Programme harnesses established relationship and a wealtth of working together over many years, to support healthcare professionals with education and training resources, focussing on genomics, genomic medicine and most importantly, in relation to specific areas of clinical practice.

Genomic testing in the NHS is being provided through a national testing network, consolidating and enhancing the existing laboratory provision. This will create a world-class genomic testing resource for the NHS and underpin the NHS Genomic Medicine Service and deliver on our commitments as part of the NHS Long Term Plan.

The national genomic testing service is delivered through a network of seven Genomic Laboratory Hubs (GLHs), each responsible for coordinating services for a particular part of the country; the North West Genomic Laboratory Hub is led by Manchester University NHS Foundation Trust and comprises delivery partners throughout the North West, including:

• Liverpool Clinical Laboratories
• Christie NHS Foundation Trust
• Lancashire Teaching Hospitals NHS Foundation Trust

The partners work as a single North West Genomics Laboratory Service to share expertise and specialist knowledge.

A range of education and training resources are available at: https://mft.nhs.uk/nwglh/nwglh-education-and-training-resources/ 

A tour of the GLH is available to view via YouTube: https://youtube.com/shorts/UiGnIQbK0Ec?feature=share

https://www.cmcanceralliance.nhs.uk/

Cheshire & Merseyside Cancer Alliance brings together organisations, patients, and others affected by cancer to drive improvements in clinical outcomes and patients’ experience of the care and treatment they receive.  The Alliance is responsible for cancer performance, quality, and outcomes across Cheshire and Merseyside and works collaboratively with NHS colleagues and partners within the third sector to champion and enable new approaches to delivering cancer services. 

Scope includes:

• Embedding cancer prevention within treatment pathways, through the principle of teachable moments
• Creating equitable access to screening programmes linked to social determinants of cancer
• Increasing GP access to diagnostics
• Improving access to radiology, pathology, and endoscopy
• Reducing emergency presentations including improved acute oncology pathways and ambulatory care.

One of our recent collaborative projects was the IMPACTT and TNA projects.  For more information on the IMPACTT project, please watch the video below.

https://gmcancer.org.uk/

The North West Genomic Medicine Service Alliance (NW GMSA) works in close collaboration with the regional cancer alliances to embed genomic medicine into cancer care across the North West. This partnership focuses on improving cancer diagnosis and treatment by leveraging genomic testing, which helps identify genetic changes and variants,  linked to specific types of cancer, such as Lynch syndrome. Through early detection, personalised treatment plans are developed to optimise patient outcomes by tailoring therapies to each patient’s unique genetic profile.

Through these efforts, we are are building a cohesive, equitable approach to cancer treatment and prevention that aligns with the NHS's commitment to precision medicine and equitable access. This collaboration is a vital step in delivering genomic-based healthcare across the region, promoting both clinical effectiveness and improved accessibility for diverse patient populations​.

The Alliance have recently produced a short animation on the subject of genomics, and genomics in cancer care. 

For more information on cancer care education and training resources available, please visit the education and training section of this website.